Majaesic Carina M, Jones Richard, Dinu Irina A, Montgomery Mark D, Sauve Reginald S, Robertson Charlene M T
Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
Pediatr Pulmonol. 2007 Sep;42(9):829-37. doi: 10.1002/ppul.20663.
The aim of this study was to determine the pulmonary sequelae of severe neonatal respiratory failure.
This was a multicenter, prospective study. Fifty-four survivors of neonatal respiratory failure (oxygenation indices >25 on two occasions), completed pulmonary function testing at 8 years of age. Thirty-one (57%) received extracorporeal membrane oxygenation (ECMO). Pulmonary outcome was based on spirometry and lung volume data. Pulmonary outcome for each diagnostic and treatment group is reported as mean and as percent predicted. Individually subjects were also classified based on spirometry, as either normal, obstructed (defined as forced expiratory volume (FEV(1)) in 1 sec:forced vital capacity (FVC) of <80 % predicted, or with reduced FVC (FCV of <80% predicted) with normal FEV(1)/FVC. Risk for adverse outcome was determined using univariate analysis.
Mean FVC, FEV(1) and FEV(25-75) were reduced in the total cohort. The reduction was greatest in the subgroup with CDH and the group treated with ECMO. Assessed individually, 54% of subjects had normal spirometry and lung volumes, 19% airflow obstruction, and 27% reduced FVC. Poorer pulmonary outcome was linked to ECMO, congenital diaphragmatic hernia (CDH), birth weight for gestational age <10th percentile, duration of hospitalization, or need for prolonged supplemental oxygen.
Neonates with severe respiratory failure due to CDH or needing ECMO and small for gestation are at increased risk of poorer pulmonary outcome and require close follow-up.
本研究旨在确定严重新生儿呼吸衰竭的肺部后遗症。
这是一项多中心前瞻性研究。54例新生儿呼吸衰竭幸存者(两次氧合指数>25)在8岁时完成了肺功能测试。31例(57%)接受了体外膜肺氧合(ECMO)治疗。肺部结局基于肺活量测定和肺容积数据。每个诊断和治疗组的肺部结局以平均值和预测百分比报告。个体也根据肺活量测定分为正常、阻塞性(定义为1秒用力呼气量(FEV(1)):用力肺活量(FVC)<预测值的80%,或FVC降低(FCV<预测值的80%)且FEV(1)/FVC正常)。使用单因素分析确定不良结局的风险。
整个队列的平均FVC、FEV(1)和FEV(25 - 75)均降低。在先天性膈疝(CDH)亚组和接受ECMO治疗的组中降低最为明显。个体评估显示,54%的受试者肺活量测定和肺容积正常,19%有气流阻塞,27%的FVC降低。较差的肺部结局与ECMO、先天性膈疝(CDH)、小于胎龄儿出生体重<第10百分位数、住院时间或需要长期补充氧气有关。
因CDH或需要ECMO且小于胎龄的严重呼吸衰竭新生儿肺部结局较差的风险增加,需要密切随访。